Cargando…
4094 Structural Determinants of Immunogenicity for Peptide-Based Immunotherapy
OBJECTIVES/GOALS: Neoantigen vaccine immunotherapies have shown promise in clinical trials, but identifying which peptides to include in a vaccine remains a challenge. We aim to establish that molecular structural features can help predict which neoantigens to target to achieve tumor regression. MET...
Autores principales: | Devlin, Jason, Alonso, Jesus, Keller, Grant, Bobisse, Sara, Harari, Alexandre, Baker, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823648/ http://dx.doi.org/10.1017/cts.2020.92 |
Ejemplares similares
-
3348 Structural Determinants of Neoantigen Immunogenicity for Cancer Therapy
por: Devlin, Jason, et al.
Publicado: (2019) -
4322 Structure-guided design of the TIL1383I T cell receptor
por: Alonso, Jesus, et al.
Publicado: (2020) -
The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients
por: Arnaud, Marion, et al.
Publicado: (2021) -
Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting
por: Schmidt, Julien, et al.
Publicado: (2021) -
4321 Personalization of T cell production for cellular immunotherapy
por: Yuan, Dennis Jinglun, et al.
Publicado: (2020)